NDC properties for "Eliquis 0.15 MG Powder for Oral Suspension" (RxCUI 2749583)
About this data
The tables show NDC propoerties for Eliquis 0.15 MG Powder for Oral Suspension with the RxCUI 2749583
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Eliquis 0.15 MG Powder for Oral Suspension (RxCUI 2749583)
| MMSL_CODE | BD41259 |
|---|---|
| RxCUI | 2749583 |
| Prescribable Synonym | Eliquis Sprinkle 0.15 MG Powder for Oral Suspension |
| RXNAV_STR | Eliquis 0.15 MG Powder for Oral Suspension |
| RxNorm Name | apixaban 0.15 MG Powder for Oral Suspension [Eliquis] |
| RxNorm Synonym | Eliquis 0.15 MG Powder for Oral Suspension |
| Related queries | Interactions (for RxCUI 2749583) |
NDC Properties
NDC Item 00003089828
| NDC 9 | 0003-0898 |
|---|---|
| NDC 10 | 0003-0898-28 |
| NDC Item | 00003089828 |
| Packaging | 28 CAPSULE in 1 BOTTLE (0003-0898-28) |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2025-09-15 |
| Marketing status | ACTIVE |
| NDA | NDA220073 |
| Related queries | Properties for NDC 9 0003-0898 |